CoChat
Sign Up
Cited by 419

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Impact of the Natural Compound Urolithin A on Health, Disease, and Aging

D’Amico, Davide, Andreux, Pénélope A., Valdés, Pamela, Singh, Anurag, Rinsch, Chris, Auwerx, Johan·2021·Trends in Molecular Medicine
DOI 10.1016/j.molmed.2021.04.009
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molmed.2021.04.009

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY-NC-ND · From the PDF
Image 2
CC-BY-NC-ND · From the PDF
Image 3
CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 62

  1. Espín, 2013, Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far, Evid. Based Complement. Alternat. Med., 2013, 270418, 10.1155/2013/270418 · DOI · Paper page
  2. Tomás-Barberán, 2017, Urolithins, the rescue of “old” metabolites to understand a “new” concept: metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status, Mol. Nutr. Food Res., 61, 1500901, 10.1002/mnfr.201500901 · DOI · Paper page
  3. González-Barrio, 2010, Bioavailability of anthocyanins and ellagitannins following consumption of raspberries by healthy humans and subjects with an ileostomy, J. Agric. Food Chem., 58, 3933, 10.1021/jf100315d · DOI
  4. Doyle, 1980, The metabolism of ellagic acid in the rat, Xenobiotica Fate Foreign Compd. Biol. Syst., 10, 247, 10.3109/00498258009033752 · DOI
  5. Cerdá, 2005, Identification of urolithin a as a metabolite produced by human colon microflora from ellagic acid and related compounds, J. Agric. Food Chem., 53, 5571, 10.1021/jf050384i · DOI · Paper page
  6. Cerdá, 2004, The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans, Eur. J. Nutr., 43, 205, 10.1007/s00394-004-0461-7 · DOI · Paper page
  7. Cerdá, 2005, Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability, J. Agric. Food Chem., 53, 227, 10.1021/jf049144d · DOI
  8. Tomás-Barberán, 2014, Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status, J. Agric. Food Chem., 62, 6535, 10.1021/jf5024615 · DOI · Paper page
  9. Cortés-Martín, 2018, The gut microbiota urolithin metabotypes revisited: the human metabolism of ellagic acid is mainly determined by aging, Food Funct., 9, 4100, 10.1039/C8FO00956B · DOI
  10. Cortés-Martín, 2020, Where to look into the puzzle of polyphenols and health? The postbiotics and gut microbiota associated with human metabotypes, Mol. Nutr. Food Res., 64, 1900952, 10.1002/mnfr.201900952 · DOI
  11. Kehoe, 2019, Nutritional challenges for older adults in Europe: current status and future directions, Proc. Nutr. Soc., 78, 221, 10.1017/S0029665118002744 · DOI
  12. Palikaras, 2018, Mechanisms of mitophagy in cellular homeostasis, physiology and pathology, Nat. Cell Biol., 20, 1013, 10.1038/s41556-018-0176-2 · DOI
  13. Ryu, 2016, Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents, Nat. Med., 22, 879, 10.1038/nm.4132 · DOI · Paper page
  14. Luan, 2021, Urolithin A improves muscle function by inducing mitophagy in muscular dystrophy, Sci. Transl. Med., 13, 10.1126/scitranslmed.abb0319 · DOI
  15. Tuohetaerbaike, 2020, Pancreas protective effects of urolithin A on type 2 diabetic mice induced by high fat and streptozotocin via regulating autophagy and AKT/mTOR signaling pathway, J. Ethnopharmacol., 250, 112479, 10.1016/j.jep.2019.112479 · DOI
  16. Lin, 2020, Urolithin A-induced mitophagy suppresses apoptosis and attenuates intervertebral disc degeneration via the AMPK signaling pathway, Free Radic. Biol. Med., 150, 109, 10.1016/j.freeradbiomed.2020.02.024 · DOI
  17. Ploumi, 2017, Mitochondrial biogenesis and clearance: a balancing act, FEBS J., 284, 183, 10.1111/febs.13820 · DOI
  18. Toney, 2019, Urolithin A, a gut metabolite, improves insulin sensitivity through augmentation of mitochondrial function and biogenesis, Obesity, 27, 612, 10.1002/oby.22404 · DOI
  19. Zou, 2019, Oral delivery of nanoparticle urolithin A normalizes cellular stress and improves survival in mouse model of cisplatin-induced AKI, Am. J. Physiol.-Ren. Physiol., 317, F1255, 10.1152/ajprenal.00346.2019 · DOI
  20. Singh, 2019, Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway, Nat. Commun., 10, 89, 10.1038/s41467-018-07859-7 · DOI · Paper page
  21. Andreux, 2019, The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans, Nat. Metab., 1, 595, 10.1038/s42255-019-0073-4 · DOI · Paper page
  22. Schooneman, 2013, Acylcarnitines, Diabetes, 62, 1, 10.2337/db12-0466 · DOI · Paper page
  23. Franceschi, 2018, Inflammaging: a new immune–metabolic viewpoint for age-related diseases, Nat. Rev. Endocrinol., 14, 576, 10.1038/s41574-018-0059-4 · DOI · Paper page
  24. Larrosa, 2010, Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism, J. Nutr. Biochem., 21, 717, 10.1016/j.jnutbio.2009.04.012 · DOI
  25. Guada, 2017, Urolithin A mitigates cisplatin-induced nephrotoxicity by inhibiting renal inflammation and apoptosis in an experimental rat model, J. Pharmacol. Exp. Ther., 363, 58, 10.1124/jpet.117.242420 · DOI
  26. Taube, 2013, Fractalkine depresses cardiomyocyte contractility, PLoS ONE, 8, 10.1371/annotation/8ea7695c-59d1-43c4-809b-fe021e07c799 · DOI
  27. Savi, 2017, In vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats, Cardiovasc. Diabetol., 16, 80, 10.1186/s12933-017-0561-3 · DOI
  28. Gong, 2019, Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice, J. Neuroinflammation, 16, 1, 10.1186/s12974-019-1450-3 · DOI
  29. Shen, 2021, Urolithin A ameliorates experimental autoimmune encephalomyelitis by targeting aryl hydrocarbon receptor, EBioMedicine, 64, 103227, 10.1016/j.ebiom.2021.103227 · DOI
  30. Komatsu, 2018, Urolithin A attenuates pro-inflammatory mediator production by suppressing PI3-K/Akt/NF-κB and JNK/AP-1 signaling pathways in lipopolysaccharide-stimulated RAW264 macrophages: possible involvement of NADPH oxidase-derived reactive oxygen species, Eur. J. Pharmacol., 833, 411, 10.1016/j.ejphar.2018.06.023 · DOI
  31. Abdelazeem, 2021, The gut microbiota metabolite urolithin A inhibits NF-κB activation in LPS stimulated BMDMs, Sci. Rep., 11, 7117, 10.1038/s41598-021-86514-6 · DOI
  32. Fu, 2019, Urolithin A targets the PI3K/Akt/NF-κB pathways and prevents IL-1β-induced inflammatory response in human osteoarthritis: in vitro and in vivo studies, Food Funct., 10, 6135, 10.1039/C9FO01332F · DOI
  33. Fang, 2019, NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome, Nat. Commun., 10, 5284, 10.1038/s41467-019-13172-8 · DOI
  34. Xia, 2020, Urolithin A exerts antiobesity effects through enhancing adipose tissue thermogenesis in mice, PLoS Biol., 18, 10.1371/journal.pbio.3000688 · DOI
  35. Ghosh, 2020, Urolithin A augments angiogenic pathways in skeletal muscle by bolstering NAD+ and SIRT1, Sci. Rep., 10, 20184, 10.1038/s41598-020-76564-7 · DOI
  36. Le Couteur, 2010, A vascular theory of aging, J. Gerontol. Ser. A, 65, 1025, 10.1093/gerona/glq135 · DOI
  37. Tang, 2017, Urolithin A alleviates myocardial ischemia/reperfusion injury via PI3K/Akt pathway, Biochem. Biophys. Res. Commun., 486, 774, 10.1016/j.bbrc.2017.03.119 · DOI
  38. Cui, 2018, Urolithin A shows anti-atherosclerotic activity via activation of class B scavenger receptor and activation of Nef2 signaling pathway, Pharmacol. Rep., 70, 519, 10.1016/j.pharep.2017.04.020 · DOI
  39. Prabhakaran, 2015, Acute stroke intervention: a systematic review, JAMA, 313, 1451, 10.1001/jama.2015.3058 · DOI
  40. Ahsan, 2019, Urolithin A-activated autophagy but not mitophagy protects against ischemic neuronal injury by inhibiting ER stress in vitro and in vivo, CNS Neurosci. Ther., 25, 976, 10.1111/cns.13136 · DOI
  41. Vergroesen, 2015, Mechanics and biology in intervertebral disc degeneration: a vicious circle, Osteoarthr. Cartil., 23, 1057, 10.1016/j.joca.2015.03.028 · DOI
  42. Liu, 2018, Urolithin A inhibits the catabolic effect of TNFα on nucleus pulposus cell and alleviates intervertebral disc degeneration in vivo, Front. Pharmacol., 9, 1043, 10.3389/fphar.2018.01043 · DOI
  43. Sairenji, 2017, An update on inflammatory bowel disease, Prim. Care, 44, 673, 10.1016/j.pop.2017.07.010 · DOI
  44. Hoste, 2018, Global epidemiology and outcomes of acute kidney injury, Nat. Rev. Nephrol., 14, 607, 10.1038/s41581-018-0052-0 · DOI · Paper page
  45. Jing, 2019, Protective effect of urolithin a on cisplatin-induced nephrotoxicity in mice via modulation of inflammation and oxidative stress, Food Chem. Toxicol., 129, 108, 10.1016/j.fct.2019.04.031 · DOI
  46. Yang, 2020, Ellagic acid and its microbial metabolite urolithin A alleviate diet-induced insulin resistance in mice, Mol. Nutr. Food Res., 64, 2000091, 10.1002/mnfr.202000091 · DOI
  47. Andreux, 2018, Mitochondrial function is impaired in the skeletal muscle of pre-frail elderly, Sci. Rep., 8, 8548, 10.1038/s41598-018-26944-x · DOI
  48. Picca, 2018, Gut dysbiosis and muscle aging: searching for novel targets against sarcopenia, Mediat. Inflamm., 2018, 7026198, 10.1155/2018/7026198 · DOI · Paper page
  49. Holmes, 2020, Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions, Transl. Res., 226, 39, 10.1016/j.trsl.2020.07.012 · DOI
  50. van Horssen, 2019, Inflammation and mitochondrial dysfunction: a vicious circle in neurodegenerative disorders?, Neurosci. Lett., 710, 132931, 10.1016/j.neulet.2017.06.050 · DOI
  51. Totiger, 2019, Urolithin A, a novel natural compound to target PI3K/AKT/mTOR pathway in pancreatic cancer, Mol. Cancer Ther., 18, 301, 10.1158/1535-7163.MCT-18-0464 · DOI
  52. Baquero, 2012, The microbiome as a human organ, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis., 18, 2
  53. Abdulrahman, 2021, Effects of urolithins on obesity-associated gut dysbiosis in rats fed on a high-fat diet, Int. J. Food Sci. Nutr., 10.1080/09637486.2021.1886255 · DOI
  54. Franco-Obregón, 2017, The microbiome-mitochondrion connection: common ancestries, common mechanisms, common goals, mSystems, 2, 10.1128/mSystems.00018-17 · DOI
  55. Selma, 2014, Gordonibacter urolithinfaciens sp. nov., a urolithin-producing bacterium isolated from the human gut, Int. J. Syst. Evol. Microbiol., 64, 2346, 10.1099/ijs.0.055095-0 · DOI
  56. Selma, 2016, The human gut microbial ecology associated with overweight and obesity determines ellagic acid metabolism, Food Funct., 7, 1769, 10.1039/C5FO01100K · DOI
  57. Romo-Vaquero, 2019, Deciphering the human gut microbiome of urolithin metabotypes: association with enterotypes and potential cardiometabolic health implications, Mol. Nutr. Food Res., 63, 10.1002/mnfr.201800958 · DOI
  58. González-Sarrías, 2017, Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: a randomized clinical trial, Mol. Nutr. Food Res., 61, 1600830, 10.1002/mnfr.201600830 · DOI
  59. Istas, 2018, Plasma urolithin metabolites correlate with improvements in endothelial function after red raspberry consumption: a double-blind randomized controlled trial, Arch. Biochem. Biophys., 651, 43, 10.1016/j.abb.2018.05.016 · DOI
  60. Davis, 2015, Definition of the Mediterranean diet; a literature review, Nutrients, 7, 9139, 10.3390/nu7115459 · DOI
  61. Diot, 2016, Mitophagy plays a central role in mitochondrial ageing, Mamm. Genome, 27, 381, 10.1007/s00335-016-9651-x · DOI
  62. Bobowska, 2021, Comparative studies of urolithins and their phase II metabolites on macrophage and neutrophil functions, European Journal of Nutrition, 60, 1957, 10.1007/s00394-020-02386-y · DOI

Cited by

Sorted by citations

See all 419

Metadata

Authors
D’Amico, D., Andreux, P. A., Valdés, P., Singh, A., Rinsch, C., & Auwerx, J.
Venue
Trends in Molecular Medicine
Publisher
Elsevier BV
Published
2021-07
Volume
27
Issue
7
Pages
687-699
ISSN
1471-4914
DOI
10.1016/j.molmed.2021.04.009
Cited by
419
References
7
Language
en
Licence
Funders
  • Universidade de Aveiro
  • Stiftung für die Erforschung der Muskelkrankheiten
  • École Polytechnique Fédérale de Lausanne

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review